Drugmakers agree to participate in second round of price negotiations
(Reuters) -All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals, whose medicines are part of the second ...
Teva Eyes High Court as Drug-Patent Listings Face Scrutiny (1)
The Federal Circuit’s refusal to reconsider its ruling forcing Teva to delist asthma-inhaler patents from the FDA’s Orange ...
KC law firms help secure $73.5M EpiPen settlement for wholesaler buyers
Mylan's settlement with drug wholesalers comes on the heels of the company reaching a $264 million settlement for consumers ...
Teva Loses Bid to Have Patent-Delisting Decision Reheard (1)
Teva Pharmaceutical Industries Ltd. failed to convince the Federal Circuit to reconsider a December ruling that five patents ...
Teva: Branded Momentum Clashes With Generic Declines And IRA Headwinds
Teva's business is encountering headwinds, including declining U.S. generics revenue. Read what this biotech plans to do in ...
Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma
Teva Hong Kong ("Teva"), has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network ...
Fierce Pharma11d
Gilead sets aside $200M for potential settlement over HIV drug speaker program
Weeks after settling a five-year patent dispute with the U.S. | Gilead set aside approximately $200 million for a potential ...
Assetmark Inc. Buys 4,851 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Assetmark Inc. boosted its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 1,370.3% ...
Teva Pharmaceutical Industries Limited (TEVA) Presents at Barclays 27th Annual Global Healthcare Conference (Transcript)
Teva Pharmaceutical Industries Limited ( NYSE: TEVA) Barclays 27th Annual Global Healthcare Conference March 11, 2025 8:00 AM ET Good morning, everyone. My name is Balaji Prasad. I'm the Senior ...